Surrozen, Inc./DE (SRZN) stock
SRZNNasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 5/30
$29.98−2.34 (-7.24%)
Close on Nov 17, 2026Market cap $352.37MP/E –Yield –
Surrozen EV/EBITDA
EV/EBITDA is enterprise value divided by EBITDA over the trailing twelve months.
No ev/ebitda figures for Surrozen
Surrozen has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.
See a number that looks wrong?